Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma: therapeutic options.

S M Connolly

    Cutis
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Scleroderma treatment focuses on managing fibrotic, vascular, and immunologic aspects. General supportive measures are also crucial for managing this complex autoimmune disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic differences based on a beef terminal index are reflected in future phenotypic performance differences in commercial beef cattle.

    Animal : an international journal of animal bioscience·2016
    Same author

    Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2015
    Same author

    Good syndrome and lichen planus: case and review.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2014
    Same author

    Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.

    International journal of pharmaceutics·2013
    Same author

    Take heart: bariatric surgery in obese patients with severe heart failure. Two case reports.

    Heart, lung & circulation·2012
    Same author

    Modulation of gastric pH by a buffered soluble effervescent formulation: A possible means of improving gastric tolerability of alendronate.

    International journal of pharmaceutics·2012
    Same journal

    Black Dots on the Scalp of a Child.

    Cutis·2026
    Same journal

    Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

    Cutis·2026
    Same journal

    Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

    Cutis·2026
    Same journal

    The Future of Psoriasis Care.

    Cutis·2026
    Same journal

    Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

    Cutis·2026
    Same journal

    Metastatic Primary Extramammary Paget Disease: A Case Series.

    Cutis·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Immunology
    • Dermatology

    Background:

    • Scleroderma, a chronic autoimmune disease, is characterized by fibrosis, vascular changes, and immune dysregulation.
    • The precise etiology of scleroderma remains unknown, necessitating a focus on symptomatic and pathogenetic treatments.

    Purpose of the Study:

    • To review current therapeutic options for scleroderma.
    • To highlight the importance of addressing fibrotic, vascular, and immunologic alterations in scleroderma management.

    Main Methods:

    • Literature review of pharmacologic advances and pathophysiological understanding of scleroderma.
    • Analysis of therapeutic strategies targeting key disease manifestations.

    Main Results:

    Related Experiment Videos

  • Pharmacologic advances offer new avenues for scleroderma treatment.
  • Therapies are typically directed at fibrotic, vascular, or immunologic components.
  • Conclusions:

    • Despite an elusive cause, scleroderma management has advanced.
    • Comprehensive treatment plans incorporating targeted therapies and general measures are essential for optimal patient outcomes.